+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 183 Pages
  • November 2023
  • Region: Global
  • 360iResearch™
  • ID: 4857894
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Microbiome Market size was estimated at USD 1.29 billion in 2022, USD 1.58 billion in 2023, and is expected to grow at a CAGR of 23.78% to reach USD 7.11 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Microbiome Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Microbiome Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Microbiome Market, highlighting leading vendors and their innovative profiles. These include 4D pharma PLC, AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Intralytix, Inc., Locus Biosciences, Inc., Merck and Co. Inc., Metabiomics Corporation, Osel Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Synthetic Biologics, Inc., Vedanta Biosciences, Inc., and Yakult Honsha Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Human Microbiome Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease
    • Acute Diarrhea
    • Autoimmune Disorders
    • Cancer
    • Diabetes
    • Mental Disorders
    • Obesity
  • Technology
    • 16s rRNA Sequencing
    • Cell Culture Technology
    • Computational Tools
    • High-Throughput Technology
    • Metagenomic Sequencing
    • Omics Technology
  • Product
    • Diagnostic Devices
    • Drugs
    • Foods
    • Prebiotic & Probiotics
  • Therapeutic Area
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Skin Disorders
    • Women’s Health
  • Application
    • Diagnostics
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Human Microbiome Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Microbiome Market?
  3. What are the technology trends and regulatory frameworks in the Human Microbiome Market?
  4. What is the market share of the leading vendors in the Human Microbiome Market?
  5. Which modes and strategic moves are suitable for entering the Human Microbiome Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Human Microbiome Market

What is the estimated value of the Global Human Microbiome Market?

The Global Human Microbiome Market was estimated to be valued at $1.58 Billion in 2023.

What is the growth rate of the Global Human Microbiome Market?

The growth rate of the Global Human Microbiome Market is 23.7%, with an estimated value of $7.11 Billion by 2030.

What is the forecasted size of the Global Human Microbiome Market?

The Global Human Microbiome Market is estimated to be worth $7.11 Billion by 2030.

Who are the key companies in the Global Human Microbiome Market?

Key companies in the Global Human Microbiome Market include 4D pharma PLC, AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V. and Finch Therapeutics Group, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Human Microbiome Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
5.1.2. Restraints
5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
5.1.3. Opportunities
5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
5.1.4. Challenges
5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Intellectual Property Landscape
6. Human Microbiome Market, by Disease
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity
7. Human Microbiome Market, by Technology
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. Human Microbiome Market, by Product
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics
9. Human Microbiome Market, by Therapeutic Area
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women’s Health
10. Human Microbiome Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. Americas Human Microbiome Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Human Microbiome Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Human Microbiome Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. 4D pharma PLC
15.1.2. AOBiome, LLC
15.1.3. Astarte Medical Partners, Inc
15.1.4. Axial Therapeutics, Inc.
15.1.5. DuPont de Nemours, Inc.
15.1.6. Enterome Bioscience
15.1.7. Evelo Biosciences, Inc.
15.1.8. Exeliom Biosciences SAS
15.1.9. Ferring B.V.
15.1.10. Finch Therapeutics Group, Inc.
15.1.11. Intralytix, Inc.
15.1.12. Locus Biosciences, Inc.
15.1.13. Merck and Co. Inc.
15.1.14. Metabiomics Corporation
15.1.15. Osel Inc.
15.1.16. Second Genome, Inc.
15.1.17. Seres Therapeutics, Inc.
15.1.18. Synlogic, Inc.
15.1.19. Synthetic Biologics, Inc.
15.1.20. Vedanta Biosciences, Inc.
15.1.21. Yakult Honsha Co., Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2022 VS 2030
FIGURE 3. HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HUMAN MICROBIOME MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. HUMAN MICROBIOME MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. HUMAN MICROBIOME MARKET DYNAMICS
FIGURE 7. HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
FIGURE 8. HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 12. HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
FIGURE 14. HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 16. HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • 4D pharma PLC
  • AOBiome, LLC
  • Astarte Medical Partners, Inc
  • Axial Therapeutics, Inc.
  • DuPont de Nemours, Inc.
  • Enterome Bioscience
  • Evelo Biosciences, Inc.
  • Exeliom Biosciences SAS
  • Ferring B.V.
  • Finch Therapeutics Group, Inc.
  • Intralytix, Inc.
  • Locus Biosciences, Inc.
  • Merck and Co. Inc.
  • Metabiomics Corporation
  • Osel Inc.
  • Second Genome, Inc.
  • Seres Therapeutics, Inc.
  • Synlogic, Inc.
  • Synthetic Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Yakult Honsha Co., Ltd.

Methodology

Loading
LOADING...